Pediatric minimally invasive surgery: laparoscopy and thoracoscopy in infants and children

Thane Blinman1, Todd Ponsky

  • 1Children's Hospital of Philadelphia, 34th and Civic Center, Philadelphia, PA 19083, USA. blinman@email.chop.edu

Pediatrics
|August 8, 2012
PubMed

Insights

Minimally invasive surgery offers benefits for pediatric patients, but challenges increase with smaller patient size. Further research is needed to make it the standard of care for infants and children.

Area of Science:

  • Pediatric surgery
  • Minimally invasive surgery
  • Surgical innovation

Background:

  • Minimally invasive surgery (MIS) presents numerous advantages for pediatric patients, including smaller incisions, reduced infection risk, and shorter hospital stays.
  • However, the benefits of MIS are challenged by increased monetary and risk-based costs that disproportionately affect smaller patients.

Purpose of the Study:

  • To review recent advancements in pediatric minimally invasive surgery.
  • To present evidence supporting the benefits of MIS for infants and children.
  • To highlight the mechanical and physiological challenges associated with performing MIS in small pediatric patients.

Main Methods:

  • Review of current literature on pediatric minimally invasive surgery.
  • Analysis of evidence for patient benefits.
  • Discussion of technical and physiological challenges encountered in MIS for infants and children.

Main Results:

  • Minimally invasive surgery offers significant benefits for pediatric patients, such as improved outcomes and reduced recovery times.
  • The application of MIS in infants and small children presents unique and substantial mechanical and physiological challenges.
  • The cost-benefit analysis of MIS in pediatrics is complex and varies with patient size.

Conclusions:

  • Pediatric minimally invasive surgery has demonstrated considerable benefits but is not yet the standard of care due to unique challenges.
  • Further research and technological advancements are necessary to overcome the obstacles of MIS in very young patients.
  • Addressing the specific risks and costs associated with MIS in infants and children is crucial for its wider adoption.